News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Patrizia Giannatempo: Thanks, ESMO for the opportunity to discuss the landmark EV-302 paper
Photo from Patrizia Giannatempo/X
May 25, 2024, 05:54

Patrizia Giannatempo: Thanks, ESMO for the opportunity to discuss the landmark EV-302 paper

Patrizia Giannatempo, Medical Oncologist at IRCCS National Cancer Institute Foundation, shared on X:

“Thanks, ESMO for the opportunity to discuss the landmark EV-302 paper in critical way.

Excellent chairs Evandro de Azambuja and Benjamin Besse.”

EV-302 paper

Source: Patrizia Giannatempo/X

Benjamin Besse cancer ESMO EV-302 Evandro de Azambuja IRCCS National Cancer Institute Foundation OncoDaily Oncology Patrizia Giannatempo
Special Coverage
Career
Apr 1, 2025, 16:02
Jay Bhattacharya begins his tenure as the 18th NIH Director - National Institutes of Health
Positive
Apr 1, 2025, 15:45
Mark Lanasa: Positive CHMP opinion for BeOne Medicines' first-line immunotherapy in ES-SCLC
Blog
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia
Blog
Apr 1, 2025, 15:04
Call for Papers: AI in Immune-Related Adverse Events (irAEs) - AI in Precision Oncology
Career
Apr 1, 2025, 14:57
Sharon Burk completes PhD with groundbreaking research - Sbarro Health Research Organization
Blog
Apr 1, 2025, 14:35
Douglas Flora: The messy truth behind healthcare's coming AI adoption
Blog
Apr 1, 2025, 14:31
Zainab Shinkafi-Bagudu: Processed meats and fried snacks may increase the risk of colorectal cancer
Societies
Apr 1, 2025, 14:08
Myeloma Paper of the Day, April 1st, suggested by Robert Orlowski
Blog
Apr 1, 2025, 12:54
CTOS Communications Committee's survey to understand your engagement with social media
Science
Apr 1, 2025, 12:48
Yan Leyfman: Dual-Targeted CAR-T Therapy Shows 100% Response in MCL
Blog
Apr 1, 2025, 12:43
By 2040, the global burden of colorectal cancer is expected to rise by 63% - Digestive Cancers Europe
Blog
Apr 1, 2025, 12:34
Asya Agulnik: Breakthrough approaches needed for pediatric cancer treatment in conflict-affected regions